View Document Preview and Link Document Date: 2014-04-23 08:40:55 Open Document File Size: 2,26 MB Share Result on Facebook
City Arnhem / Holzgerlingen / Maastricht / Stuttgart / / Company Press Release Curetis AG / Cempra Inc. / Sanofi / Contact Curetis AG / Curetis AG / / Continent Europe / / Country Germany / Russia / United States / Netherlands / Canada / / Currency pence / USD / EUR / / / Event Business Partnership / Funding / FDA Phase / / Facility Maastricht University Medical Center / / IndustryTerm diagnostic solutions / molecular diagnostic solutions / or transfer any product / / MedicalCondition Pseudomonas / pneumonia / Unyvero™ P50 Pneumonia / ventilator-associated pneumonia / tissue infections / severe infectious diseases / / Organization Department of Medical Microbiology / Royal Dutch Society for Microbiology / FDA / Maastricht University Medical Center / Dutch Association for Environmental Medicine / / Person Gerd Luedke / Ludger Wess / / / Position Director Bio-Assay Development / / Product CAUTION - Investigational device / Unyvero application / Unyvero / NCT01922024 / CAUTION - Investigational / / Region Middle East / / Technology Unyvero™ technology / / URL http / SocialTag 
Press Release Curetis AG New Favorable Clinical Evaluation Data for Unyvero™ P50 Pneumonia Application − Dutch study demonstrates excellent sensitivity of Unyvero™ cartridges